These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25764004)

  • 1. Factors associated with resistant hypertension in a large cohort of hypertensive patients: the Pol-Fokus study.
    Prejbisz A; Klocek M; Gąsowski J; Topór-Mądry R; Leśniak W; Kabat M; Czarnecka D; Kawecka-Jaszcz K; Narkiewicz K; Januszewicz A
    Pol Arch Med Wewn; 2015; 125(4):249-59. PubMed ID: 25764004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between gender and clinical characteristics, associated factors, and hypertension treatment in patients with resistant hypertension.
    Hanus KM; Prejbisz A; Gąsowski J; Klocek M; Topór-Mądry R; Leśniak W; Kabat M; Czarnecka D; Kawecka-Jaszcz K; Narkiewicz K; Januszewicz A
    Kardiol Pol; 2017; 75(5):421-431. PubMed ID: 28150289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.
    Tsioufis C; Kasiakogias A; Kordalis A; Dimitriadis K; Thomopoulos C; Tsiachris D; Vasileiou P; Doumas M; Makris T; Papademetriou V; Kallikazaros I; Bakris G; Stefanadis C
    J Hypertens; 2014 Feb; 32(2):415-22. PubMed ID: 24241057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated risk factors of resistant hypertension among Chinese hypertensive patients in primary care setting.
    Chan KK; Chiang L; Choi CC; Li Y; Chen CX
    BMC Prim Care; 2024 Apr; 25(1):120. PubMed ID: 38641566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for resistant hypertension among hypertensive patients from a developing country.
    Kumara WA; Perera T; Dissanayake M; Ranasinghe P; Constantine GR
    BMC Res Notes; 2013 Sep; 6():373. PubMed ID: 24053215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Bacan G; Ataíde DS; Gorgonio LKC; Salles GF
    Diabetes Care; 2020 Jan; 43(1):219-227. PubMed ID: 31619394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistant arterial hypertension in Primary Care patients in Spain. PRESCAP Study 2010].
    Cinza-Sanjurjo S; Alonso-Moreno FJ; Prieto-Díaz MÁ; Divisón-Garrote JA; Rodríguez-Roca GC; Llisterri-Caro JL;
    Semergen; 2015 Apr; 41(3):123-30. PubMed ID: 24768029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
    Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
    J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prevalence of Japanese Outpatients with Hypertension Who Meet the Definition of Treatment Resistant Hypertension and Are Eligible for Enrolment in Clinical Trials of Endovascular Ultrasound Renal Denervation.
    Okamura K; Shirai K; Okuda T; Urata H
    Intern Med; 2018 Jan; 57(1):1-12. PubMed ID: 29033430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between accessory renal arteries and resistant hypertension: A cohort study.
    Maisons V; Le Jeune S; Barber-Chamoux N; Boudghene-Stambouli F; Brucker M; Delsart P; Lopez-Sublet M; Perez L; Radhouani I; Sosner P; Sautenet B
    J Med Vasc; 2023 Feb; 48(1):18-23. PubMed ID: 37120265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management Practices in Indian Patients with Uncontrolled Hypertension.
    Bharatia R; Chitale M; Saxena GN; Kumar RG; Chikkalingaiah ; Trailokya A; Dalvi K; Talele S
    J Assoc Physicians India; 2016 Jul; 64(7):14-21. PubMed ID: 27759337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between visceral adipose index and resistant hypertension in people living with diabetes.
    Gökalp G; Özbeyaz NB
    Postgrad Med; 2023 Jun; 135(5):524-529. PubMed ID: 37208867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visfatin levels are increased in patients with resistant hypertension and are correlated with left ventricular hypertrophy.
    Ozal E; Sahin I; Bolat I; Pusuroglu H; Avci II; Akgul O; Ornek V; Sürgit O; Yildirim A
    Blood Press Monit; 2017 Jun; 22(3):137-142. PubMed ID: 28240682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive treatment is not a risk factor for major cardiovascular events in the Gubbio residential cohort study.
    Lanti M; Puddu PE; Vagnarelli OT; Laurenzi M; Cirillo M; Mancini M; Zanchetti A; Menotti A
    J Hypertens; 2015 Apr; 33(4):736-44; discussion 744. PubMed ID: 25915878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease].
    Cordero A; Bertomeu-Martínez V; Mazón P; Fácila L; Bertomeu-González V; Cosín J; Galve E; Núñez J; Lekuona I; González-Juanatey JR
    Rev Esp Cardiol; 2011 Jul; 64(7):587-93. PubMed ID: 21640460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP2B1 gene polymorphisms associated with resistant hypertension in the Japanese population.
    Kobayashi Y; Yatsu K; Haruna A; Kawano R; Ozawa M; Haze T; Komiya S; Suzuki S; Ohki Y; Fujiwara A; Saka S; Hirawa N; Toya Y; Tamura K
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):355-362. PubMed ID: 38430457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant hypertension in patients with type 2 diabetes: clinical correlates and association with complications.
    Solini A; Zoppini G; Orsi E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Arosio M; Baroni MG; Penno G; Pugliese G;
    J Hypertens; 2014 Dec; 32(12):2401-10; discussion 2410. PubMed ID: 25198422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
    Yan Z; Wang Y; Li S; Wang J; Zhang L; Tan H; Li S; Yang L; Pei H; Zhang L; Wang Y; Duan J; Jiao S; Zhao M; Fu S;
    Am J Hypertens; 2018 Mar; 31(4):486-494. PubMed ID: 29304216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
    de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
    BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.